Respiratory Distress Syndrome Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global Respiratory Distress Syndrome Market size is projected to reach US$ 551.9 million by 2028, from US$ 377.7 million in 2021, at a CAGR of 5% during the forecast period 2022-2028.

Respiratory distress syndrome is caused by a deficiency of pulmonary surfactant in the lungs of newborns, most commonly in people born less than 37 weeks of gestation. The risk increases with the degree of immaturity. Symptoms and signs include grunting breathing, use of the accessory muscles, and a runny nose immediately after birth. Diagnosis is clinical. A fetal lung maturity test can assess prenatal risk. Treatment is surfactant therapy and supportive therapy. Treatment for RDS usually begins as soon as the newborn is born and sometimes in the delivery room. Treatment of RDS includes surfactant replacement therapy, respiratory support on a ventilator or continuous positive nasal pressure device (NCPAP), or other adjuvant therapy.

Market Segments

By Type

• Poractant Alfa
• Beractant
• Calfactant
• Others

By Application

• Very Preterm Infants
• Moderate to Late Preterm Infants
• Others

Key Players

• Chiesi Farmaceutici
• CR-Double Crane
• ONY Biotech
• AbbVie
• Yuhan Corporation
• JW Pharmaceuticals
• Noargen

Scope of the Report

The research study analyzes the global Respiratory Distress Syndrome industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Respiratory Distress Syndrome Market Report

1. What was the Respiratory Distress Syndrome Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Respiratory Distress Syndrome Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Respiratory Distress Syndrome Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.